FI953830A - Screening av graviditetsavvikelser före födseln - Google Patents

Screening av graviditetsavvikelser före födseln Download PDF

Info

Publication number
FI953830A
FI953830A FI953830A FI953830A FI953830A FI 953830 A FI953830 A FI 953830A FI 953830 A FI953830 A FI 953830A FI 953830 A FI953830 A FI 953830A FI 953830 A FI953830 A FI 953830A
Authority
FI
Finland
Prior art keywords
marker
level
screening
woman
pregnant
Prior art date
Application number
FI953830A
Other languages
English (en)
Finnish (fi)
Other versions
FI953830A0 (sv
FI119451B (sv
Inventor
Andrew Jonathan Beard
Adrian Charles Dawkes
Christopher John Davies
Original Assignee
Johnson & Johnson Clin Diag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Clin Diag filed Critical Johnson & Johnson Clin Diag
Publication of FI953830A0 publication Critical patent/FI953830A0/sv
Publication of FI953830A publication Critical patent/FI953830A/sv
Application granted granted Critical
Publication of FI119451B publication Critical patent/FI119451B/sv

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/38—Pediatrics
    • G01N2800/385—Congenital anomalies
    • G01N2800/387—Down syndrome; Trisomy 18; Trisomy 13
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/817—Steroids or hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Medical Informatics (AREA)
  • Reproductive Health (AREA)
  • Public Health (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Steroid Compounds (AREA)
  • Fire Alarms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FI953830A 1994-08-13 1995-08-11 Screening av graviditetsavvikelser före födseln FI119451B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9416415 1994-08-13
GB9416415A GB9416415D0 (en) 1994-08-13 1994-08-13 Antenatel screening for pregnacy abnormalities

Publications (3)

Publication Number Publication Date
FI953830A0 FI953830A0 (sv) 1995-08-11
FI953830A true FI953830A (sv) 1996-02-14
FI119451B FI119451B (sv) 2008-11-14

Family

ID=10759858

Family Applications (1)

Application Number Title Priority Date Filing Date
FI953830A FI119451B (sv) 1994-08-13 1995-08-11 Screening av graviditetsavvikelser före födseln

Country Status (10)

Country Link
US (1) US6022695A (sv)
EP (1) EP0701131B1 (sv)
JP (1) JP3626251B2 (sv)
KR (1) KR100389988B1 (sv)
AT (1) ATE213334T1 (sv)
AU (1) AU698204B2 (sv)
CA (1) CA2155919C (sv)
DE (1) DE69525400T2 (sv)
FI (1) FI119451B (sv)
GB (1) GB9416415D0 (sv)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9606261D0 (en) * 1996-03-25 1996-05-29 Johnson & Johnson Clin Diag Prenatal screening for fetal abnormalities
GB9614615D0 (en) * 1996-07-11 1996-09-04 Isis Innovation Diagnosis of pre-eclampsia
US6620590B2 (en) 1996-07-11 2003-09-16 Isis Innovation Limited Diagnosis of pre-eclampsia
US20050131738A1 (en) * 2002-05-15 2005-06-16 Morris Tommy J. System and method for handling medical information
CA2486089C (en) 2002-05-15 2013-12-17 Tommy J. Morris System and method for handling medical information
US7315787B2 (en) * 2003-10-07 2008-01-01 Ntd Laboratories, Inc. Multi-marker screening protocol for fetal abnormalities
RU2373842C2 (ru) * 2003-12-02 2009-11-27 Шрага РОТТЕМ Искусственный интеллект и устройство для диагностики, скрининга, профилактики и лечения состояний системы матери и плода
US20070249531A1 (en) * 2004-02-20 2007-10-25 Aplagen Gmbh Method for the Detection of Autoantibodies Against Specific Peptides and Its Use in Diagnosis and Treatment of Pregnancy-Loss or Infertility
ATE538217T1 (de) * 2007-07-02 2012-01-15 Univ Edinburgh Erkennung von ektopischen schwangerschaften
US20100027571A1 (en) * 2008-07-31 2010-02-04 Murdoch Keith M Stabilized near-infrared laser
WO2011144999A1 (en) 2010-05-17 2011-11-24 Sandra Reznik Plasma protein-a2 (papp-a2) as a marker for detecting risk of chromosomal abnormalities
CN116358954A (zh) * 2023-02-22 2023-06-30 深圳市昭蓝生物科技有限公司 复合质控品及其制备方法和产前筛查试剂盒

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874693A (en) * 1986-10-10 1989-10-17 Mark Bogart Method for assessing placental dysfunction
DE3882140T2 (de) * 1987-07-09 1993-12-23 3I Research Exploit Ltd Pränatales screening für downs-syndrom.
GB8816714D0 (en) * 1988-07-14 1988-08-17 Univ Court Of University Of Gl Switched reluctance motors
EP0409956B2 (en) * 1989-01-17 2004-07-21 MACRI, James N. Down syndrome screening method
GB9224965D0 (en) * 1992-11-28 1993-01-20 Kodak Ltd Antenatal screening for chromosomal abnormalities
GB9410345D0 (en) * 1994-05-24 1994-07-13 Univ Oxford Brookes Method of genetic testing
US5716853A (en) * 1995-07-07 1998-02-10 Chiron Diagnostics Corporation Prenatal down syndrome screening with assays specific for UGP

Also Published As

Publication number Publication date
EP0701131B1 (en) 2002-02-13
DE69525400D1 (de) 2002-03-21
KR100389988B1 (ko) 2003-12-06
FI953830A0 (sv) 1995-08-11
AU2848795A (en) 1996-02-29
DE69525400T2 (de) 2002-07-18
CA2155919C (en) 2007-06-05
US6022695A (en) 2000-02-08
JP3626251B2 (ja) 2005-03-02
AU698204B2 (en) 1998-10-29
ATE213334T1 (de) 2002-02-15
KR960008312A (ko) 1996-03-22
FI119451B (sv) 2008-11-14
EP0701131A2 (en) 1996-03-13
JPH09113508A (ja) 1997-05-02
EP0701131A3 (en) 1996-05-29
CA2155919A1 (en) 1996-02-14
GB9416415D0 (en) 1994-10-05

Similar Documents

Publication Publication Date Title
De Biasio et al. First‐trimester screening for Down syndrome using nuchal translucency measurement with free β‐hCG and PAPP‐A between 10 and 13 weeks of pregnancy—the combined test
FI953830A0 (sv) Screening av graviditetsavvikelser före födseln
DK0627082T3 (da) Antenatal screening for kromosomale abnormaliteter
PT923730E (pt) Rastreio pré-natal da síndrome de down utilizando gonadotrofina hiperglicosilada
Öney et al. The value of the mean arterial blood pressure in the second trimester (MAP-2 value) as a predictor of pregnancy-induced hypertension and preeclampsia. A preliminary report
ATE227024T1 (de) Verfahren und vorrichtung zur feststellung des down-syndroms durch nichtinvasive analyse von mütterlichem blut
DE3882140D1 (en) Praenatales screening fuer downs-syndrom.
Vollebergh et al. The accuracy of ultrasonic measurement of fetal crown-rump length
SG52419A1 (en) Antenatal screening for chromosomal abnormalities
GB9315230D0 (en) Antenatal screening for chromosomal abnormalities
Zoppi et al. Can fetal iliac bone measurement be used as a marker for Down's syndrome screening?
ATE240525T1 (de) Pränatales testverfahren für down-syndrom
Haddad et al. Severe uterine diastolic notch as a prognostic factor in preeclamptic women
Wenger et al. First trimester maternal serum α‐fetoprotein screening for Down syndrome and other aneuploidies
AHMED et al. Determination of the stage of gestation by the assay of chorionic gonadotrophin and Schwangerschaftsprotein 1
Agree TESTING FOR PREGNANCY
Easterling et al. Maternal weight, hemodynamics, and preeclampsia
Preboth Fetal screening in the first trimester
Phillips et al. Abnormal maternal serum screening results and ultrasonography: Part II: Screen-positive for chromosome abnormalities

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: ORTHO-CLINICAL DIAGNOSTICS, INC.

Free format text: ORTHO-CLINICAL DIAGNOSTICS, INC.

FG Patent granted

Ref document number: 119451

Country of ref document: FI

MA Patent expired